We are live on ! Find out more
RCG

Rock Creek Group Portfolio holdings

AUM $988M
1-Year Est. Return 8.89%
This Fund
S&P 500
This Quarter Est. Return
+2.82%
1 Year Est. Return
+8.89%
3 Year Est. Return
+34.87%
5 Year Est. Return
+44.81%
10 Year Est. Return
AUM
$219M
AUM Growth
-$5.48M
Cap. Flow
-$4.83M
Cap. Flow %
-2.21%
Top 10 Hldgs %
50.51%
Holding
137
New
58
Increased
17
Reduced
31
Closed
26

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 13.25%
2 Technology 12.19%
3 Healthcare 9.43%
4 Financials 9.22%
5 Consumer Staples 4.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PXD
76
DELISTED
Pioneer Natural Resource Co.
PXD
$563K 0.26%
3,660
-3,704
-50% -$568K
AX icon
77
Axos Financial
AX
$5.45B
$545K 0.25%
+20,000
New +$589K
FXI icon
78
iShares China Large-Cap ETF
FXI
$4.31B
$535K 0.24%
12,500
AMZN icon
79
Amazon
AMZN
$2.5T
$507K 0.23%
5,360
+40
+0.8% +$3.73K
DHI icon
80
D.R. Horton
DHI
$41B
$504K 0.23%
+11,688
New +$517K
NRE
81
DELISTED
NorthStar Realty Europe Corp.
NRE
$480K 0.22%
+29,200
New +$495K
EA icon
82
Electronic Arts
EA
$52.4B
$471K 0.22%
+4,656
New +$444K
IEFA icon
83
iShares Core MSCI EAFE ETF
IEFA
$186B
$459K 0.21%
+7,477
New +$458K
CUE icon
84
Cue Biopharma
CUE
$135M
$447K 0.2%
+1,657
New +$412K
IEMG icon
85
iShares Core MSCI Emerging Markets ETF
IEMG
$149B
$438K 0.2%
+8,514
New +$435K
BKNG icon
86
Booking.com
BKNG
$138B
$433K 0.2%
5,775
-1,775
-24% -$128K
LOW icon
87
Lowe's Companies
LOW
$116B
$432K 0.2%
4,285
-4,541
-51% -$479K
NBIS
88
Nebius Group N.V.
NBIS
$47.7B
$429K 0.2%
11,280
-20,300
-64% -$754K
GLMD icon
89
Galmed Pharmaceuticals
GLMD
$3.94M
$420K 0.19%
+318
New +$410K
AGN
90
DELISTED
Allergan plc
AGN
$419K 0.19%
+2,500
New +$346K
PLAY icon
91
Dave & Buster's
PLAY
$343M
$405K 0.18%
+10,000
New +$509K
PINC
92
DELISTED
Premier
PINC
$391K 0.18%
+10,000
New +$361K
ECH icon
93
iShares MSCI Chile ETF
ECH
$1.01B
$362K 0.17%
8,867
-47,938
-84% -$1.99M
CNC icon
94
Centene
CNC
$31.3B
$361K 0.16%
6,891
-6,935
-50% -$375K
PVLA
95
Palvella Therapeutics
PVLA
$1.98B
$353K 0.16%
+938
New +$280K
BBY icon
96
Best Buy
BBY
$18B
$334K 0.15%
+4,783
New +$334K
BIIB icon
97
Biogen
BIIB
$29.9B
$300K 0.14%
1,283
-113
-8% -$26.1K
MU icon
98
Micron Technology
MU
$1.04T
$294K 0.13%
+7,615
New +$290K
MYOK
99
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$270K 0.12%
+5,394
New +$263K
APTO
100
DELISTED
Aptose Biosciences, Inc.
APTO
$255K 0.12%
+217
New +$200K

Similar funds

Rock Creek Group's Q2 2019 Portfolio in Review

As of Q2 2019, Rock Creek Group held 137 positions worth $219M, down 2.4% from $225M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Rock Creek Group's Q2 2019 filing shows 58 new, 17 increased, 31 reduced and 26 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 25,718 shares worth $7.58M. The largest sale was Alibaba, an estimated $28.6M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 13% of assets, down from 31% a quarter earlier, followed by Technology and Healthcare.

  • Rock Creek Group's largest Q2 2019 buy was iShares Core S&P 500 ETF: 25,718 shares worth $7.58M.
  • Rock Creek Group added most to PIMCO Enhanced Short Maturity Active Exchange-Traded Fund in Q2 2019, an estimated $15.3M increase.
  • Rock Creek Group's biggest Q2 2019 reduction was Alibaba, cutting an estimated $28.6M.
  • Rock Creek Group fully exited Huazhu Hotels Group in Q2 2019, selling an estimated $6.42M.
  • Rock Creek Group's ten largest holdings make up 51% of its $219M portfolio in Q2 2019.
  • Rock Creek Group opened 58 new positions and closed 26 in Q2 2019.
  • Rock Creek Group's portfolio value fell 2.4% quarter-over-quarter to $219M.

Based on Rock Creek Group's 13F filing for Q2 2019, filed 14 Aug 2019.